Franklin Bickle, OD
Optometrist · Granville, OHNPI 1225012958
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,275 of the $5,157 with a category attached, or 63.5%. 15 manufacturers reported payments, led by Coopervision Inc. at 46.0% of the total. Reporting peaked in 2021 at $2,411 and has fallen 65.2% since, to $839 in 2025. Among optometrist clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 54 payments — averaging $95.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$2K
- Bausch & Lomb Americas Inc.$750
- Bausch & Lomb, A Division Of Bausch Health US, LLC$466
- Tarsus Pharmaceuticals, Inc.$304
- Johnson & Johnson Vision Care, Inc.$300
- Eyevance Pharmaceuticals LLC$165
- plus $803 from 9 others
Across 2 payments — averaging $30.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$60
What the payments were for
- Consulting fees$1,80035%
- Food & beverage$3,27564%
- Entertainment$822%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 12 | $2,370 |
| Bausch & Lomb Americas Inc. | 10 | $750 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 9 | $466 |
| Tarsus Pharmaceuticals, Inc. | 5 | $304 |
| Johnson & Johnson Vision Care, Inc. | 3 | $300 |
| Eyevance Pharmaceuticals LLC | 1 | $165 |
| Optos, Inc. | 2 | $148 |
| Apellis Pharmaceuticals, Inc. | 1 | $125 |
| Dompe US, Inc. | 1 | $124 |
| Kala Pharmaceuticals, Inc. | 1 | $122 |
| Optovue, Inc. | 1 | $117 |
| Biotissue Holdings Inc. | 3 | $59 |
| Maculogix, Inc. | 2 | $56 |
| AbbVie | 2 | $33 |
| Thea Pharma Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MyDay Contact Lens$1,800
- INFUSE$611
- XDEMVY$256
- MIEBO$250
- Acuvue$240
- Tobradex ST$165
- Syfovre$125
- XIIDRA$125
- Oxervate$124
- EYSUVIS$122
- XR$117
- Multiple Brands Contact Lens$115
- BIOTRUE ONE DAY$103
How this compares
$5,157 in reported general payments places this provider in the 90th percentile of 1,995 optometrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 16 | $513 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 27 | $214 |
| Latanoprost | 30 | $207 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Granville
- Katherine BickleGranville$40K
- Mile BrujicBowling Green$1.3M
- Gregory DenaeyerColumbus$846K
- Cory LappinMontgomery$367K
- Chris SmileyColumbus$305K
- Thomas ChesterCleveland$300K
- Carly RoseCincinnati$203K
- Wendy HallierReynoldsburg$200K
- John LahrCincinnati$145K
- Erin RueffColumbus$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.